United Laboratories International Holdings Ltd. (U
Post# of 250675
Posted On: 11/17/2014 2:46:41 AM
United Laboratories International Holdings Ltd. (ULIHF) Financials Nov 3, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for United Laboratories International Holdings Ltd.
Fiscal year is January-December. All values HKD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 4.64B 6.5B 6.41B 7.02B 7.65B
Cost of Goods Sold (COGS) incl. D&A 2.83B 3.94B 4.58B 4.93B 5.08B
COGS excluding D&A 2.49B 3.52B 4.13B 4.39B 4.5B
Depreciation & Amortization Expense 338.52M 419.13M 457.24M 539.96M 574.56M
Depreciation 334.1M 414.11M 453.46M 534.98M 567.77M
Amortization of Intangibles 1.86M 2.35M 1.08M 1.43M 2.22M
Gross Income 1.81B 2.57B 1.82B 2.09B 2.57B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 1.02B 1.35B 1.55B 1.73B 1.9B
Research & Development 13.35M 51.9M 67.86M 64.37M 111.47M
Other SG&A 1.01B 1.3B 1.49B 1.67B 1.79B
Other Operating Expense 31.02M 18.24M 36.04M 19.96M 146.31M
Unusual Expense 0 (2.27M) (1.49M) (59.32M) (479.97M)
EBIT after Unusual Expense 0 2.27M 1.49M 59.32M 479.97M
Non Operating Income/Expense 18.71M 48.63M 92.7M 49.8M 69.22M
Non-Operating Interest Income 3.59M 5.76M 11.64M 19.73M 25.2M
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 88.49M 91.82M 154.75M 214.93M 201.15M
Gross Interest Expense 105.77M 114.82M 199.73M 349.71M 471.32M
Interest Capitalized 17.28M 23M 44.98M 134.78M 270.18M
Pretax Income 693.37M 1.16B 183.19M 248.31M 901.35M
Income Tax 151.93M 189.12M 78.92M 86.34M 853.31M
Income Tax - Current Domestic 18.51M 10.35M 7.63M 1.38M 5.66M
Income Tax - Current Foreign 112.32M 168.28M 78.67M 103.49M 111.07M
Income Tax - Deferred Domestic 21.1M 10.49M (7.39M) (18.53M) 736.59M
Income Tax - Deferred Foreign - - - - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 541.44M 974.16M 104.27M 161.98M 48.04M
Minority Interest Expense 0 0 0 0 0
Net Income 541.44M 974.16M 104.27M 161.98M 48.04M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 541.44M 974.16M 104.27M 161.98M 48.04M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 541.44M 974.16M 104.27M 161.98M 48.04M
EPS (Basic) 0.41 0.72 0.07 0.11 0.03
Basic Shares Outstanding 1.31B 1.36B 1.42B 1.51B 1.63B
EPS (Diluted) 0.41 0.72 0.07 0.11 0.03
Diluted Shares Outstanding 1.31B 1.36B 1.42B 1.51B 1.63B
EBITDA 1.1B 1.62B 689.35M 874.35M 1.1B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for United Laboratories International Holdings Ltd.
Fiscal year is January-December. All values HKD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 4.64B 6.5B 6.41B 7.02B 7.65B
Cost of Goods Sold (COGS) incl. D&A 2.83B 3.94B 4.58B 4.93B 5.08B
COGS excluding D&A 2.49B 3.52B 4.13B 4.39B 4.5B
Depreciation & Amortization Expense 338.52M 419.13M 457.24M 539.96M 574.56M
Depreciation 334.1M 414.11M 453.46M 534.98M 567.77M
Amortization of Intangibles 1.86M 2.35M 1.08M 1.43M 2.22M
Gross Income 1.81B 2.57B 1.82B 2.09B 2.57B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 1.02B 1.35B 1.55B 1.73B 1.9B
Research & Development 13.35M 51.9M 67.86M 64.37M 111.47M
Other SG&A 1.01B 1.3B 1.49B 1.67B 1.79B
Other Operating Expense 31.02M 18.24M 36.04M 19.96M 146.31M
Unusual Expense 0 (2.27M) (1.49M) (59.32M) (479.97M)
EBIT after Unusual Expense 0 2.27M 1.49M 59.32M 479.97M
Non Operating Income/Expense 18.71M 48.63M 92.7M 49.8M 69.22M
Non-Operating Interest Income 3.59M 5.76M 11.64M 19.73M 25.2M
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 88.49M 91.82M 154.75M 214.93M 201.15M
Gross Interest Expense 105.77M 114.82M 199.73M 349.71M 471.32M
Interest Capitalized 17.28M 23M 44.98M 134.78M 270.18M
Pretax Income 693.37M 1.16B 183.19M 248.31M 901.35M
Income Tax 151.93M 189.12M 78.92M 86.34M 853.31M
Income Tax - Current Domestic 18.51M 10.35M 7.63M 1.38M 5.66M
Income Tax - Current Foreign 112.32M 168.28M 78.67M 103.49M 111.07M
Income Tax - Deferred Domestic 21.1M 10.49M (7.39M) (18.53M) 736.59M
Income Tax - Deferred Foreign - - - - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 541.44M 974.16M 104.27M 161.98M 48.04M
Minority Interest Expense 0 0 0 0 0
Net Income 541.44M 974.16M 104.27M 161.98M 48.04M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 541.44M 974.16M 104.27M 161.98M 48.04M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 541.44M 974.16M 104.27M 161.98M 48.04M
EPS (Basic) 0.41 0.72 0.07 0.11 0.03
Basic Shares Outstanding 1.31B 1.36B 1.42B 1.51B 1.63B
EPS (Diluted) 0.41 0.72 0.07 0.11 0.03
Diluted Shares Outstanding 1.31B 1.36B 1.42B 1.51B 1.63B
EBITDA 1.1B 1.62B 689.35M 874.35M 1.1B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)